Search Within

Kai Dannebom Rejeski

Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
  3. Review (7)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (22)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Bone Marrow Transplant (15)
  5. GME, Medicine (15)
  6. Graduate Medical Education (15)

More Groups

People
  1. Roni Shouval (20)
  2. Miguel-Angel Perales (15)
  3. Gilles Salles (11)
  4. Jae Park (11)
  5. Maria Palomba (10)
  6. Gunjan Shah (9)

More People

Years
  1. 2025 (15)
  2. 2024 (20)
Publications
  1. Blood (11)
  2. Blood Advances (3)
  3. Bone Marrow Transplantation (3)
  4. Blood Cancer Journal (2)
  5. HemaSphere (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Elsevier Science, Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity
    Journal Article

    Liang, E. C.; Rejeski, K.; Fei, T.; Albittar, A.; Huang, J. J.; Portuguese, A. J.; Wu, Q.; Raj, S.; Subklewe, M.; Shouval, R.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • T-cell malignant neoplasms after chimeric antigen receptor T-cell therapy
    Research Letter

    Storgard, R.; Rejeski, K.; Perales, M. A.; Goldman, A.; Shouval, R.
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells
    Journal Article

    Iacoboni, G.; Sánchez-Salinas, M. A.; Rejeski, K.; Martín-López, A. A.; Kwon, M.; Navarro, V.; Jalowiec, K. A.; Hernani, R.; Reguera-Ortega, J. L.; Gallur, L.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated haematotoxicity after CAR T-cell therapy: From mechanism to management
    Review

    Rejeski, K.; Jain, M. D.; Shah, N. N.; Perales, M. A.; Subklewe, M.
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Navigating the prognostic role of transfusions after CAR-T
    Editorial

    Alhomoud, M.; Rejeski, K.
    Blood Advances (2024)

    Fulltext@MSK | Save